Commercial Credit Report for Jeisys Medical Inc

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Jeisys Medical Inc is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jeisys Medical Inc

76, Eulji-ro, Jung-gu

Phone: +82 226036417p:+82 226036417

SEOUL, 08501 South Korea

Fax: +82 237702686f:+82 237702686

This company was Merged or Acquired on 9/11/2024.

This company is no longer actively traded on any major stock exchange.

This is a Subsidiary, click here for the Parent Company

Business Summary

Jeisys Medical Inc is a Korea-based company principally engaged in the manufacturing and distribution of medical devices. The Company manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and LinearZ. In addition, the Company also provides consumables such as cartridges and tips.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	Yes	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
3844	X-ray apparatus and tubes and related irradiation apparatus
3845	Electromedical and electrotherapeutic apparatus
3841	Surgical and medical instruments and apparatus

Officers and Directors

Title	Name	Age	Title Date	Start Date
Chief Executive Officer, Director	Jae HanLee	59	3/26/2024	3/26/2024
Vice President	Myeong HunKim	53
Managing Director	Won JuLee	64
11 additional Officers and Directors records available in full report.

General Information

Outstanding Shares:	74,485,307	(As of 9/10/2024)
Shareholders:	24,156
Stock Exchange:	KDQ
Fax Number:	+82 237702686

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN